Johnson & Johnson (JNJ) Insider Trading
Directors, officers and holders of more than 10% of JNJ report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 488 transactions on file: 0 with code P, 11 with code S and 39 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | Pinto Daniel E | Director | A Award | 113 | $276.31 | $31,250 |
| Sep 8, 2026 | HEWSON MARILLYN A | Director | A Award | 181 | $276.31 | $50,000 |
| Sep 8, 2026 | Woods Eugene A. | Director | A Award | 136 | $276.31 | $37,500 |
| Sep 2, 2026 | Schmid Timothy | EVP, WW Chair, MedTech | M Exercise | 11,070 | $131.94 | $1,460,576 |
| Sep 2, 2026 | Schmid Timothy | EVP, WW Chair, MedTech | M Exercise | 22,527 | $151.41 | $3,410,813 |
| Sep 2, 2026 | Schmid Timothy | EVP, WW Chair, MedTech | S Sale | 11,070 | $274.74 | $3,041,372 |
| Sep 2, 2026 | Schmid Timothy | EVP, WW Chair, MedTech | M Exercise | 22,527 | Not measured | Not measured |
| Sep 2, 2026 | Schmid Timothy | EVP, WW Chair, MedTech | M Exercise | 11,070 | Not measured | Not measured |
| Sep 2, 2026 | Schmid Timothy | EVP, WW Chair, MedTech | S Sale | 22,527 | $274.74 | $6,189,068 |
| Aug 17, 2026 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | S Sale | 15,000 | $263.36 | $3,950,400 |
| Aug 17, 2026 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M Exercise | 15,000 | $115.67 | $1,735,050 |
| Aug 17, 2026 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M Exercise | 15,000 | Not measured | Not measured |
| Aug 13, 2026 | Duato Joaquin | CEO and Chairman of the Board | M Exercise | 123,291 | Not measured | Not measured |
| Aug 13, 2026 | Duato Joaquin | CEO and Chairman of the Board | S Sale | 20,976 | $262.00 | $5,495,712 |
| Aug 13, 2026 | Duato Joaquin | CEO and Chairman of the Board | S Sale | 102,315 | $261.00 | $26,704,215 |
| Aug 13, 2026 | Duato Joaquin | CEO and Chairman of the Board | M Exercise | 123,291 | $115.67 | $14,261,070 |
| Aug 6, 2026 | Forminard Elizabeth | EVP, Chief Legal Officer | S Sale | 9,344 | $257.75 | $2,408,463 |
| Aug 6, 2026 | Forminard Elizabeth | EVP, Chief Legal Officer | S Sale | 6,574 | $255.93 | $1,682,497 |
| Aug 6, 2026 | Forminard Elizabeth | EVP, Chief Legal Officer | M Exercise | 9,344 | $131.94 | $1,232,847 |
| Aug 6, 2026 | Forminard Elizabeth | EVP, Chief Legal Officer | M Exercise | 9,344 | Not measured | Not measured |
| Aug 5, 2026 | Duato Joaquin | CEO and Chairman of the Board | S Sale | 41,957 | $258.06 | $10,827,256 |
| Aug 5, 2026 | Duato Joaquin | CEO and Chairman of the Board | S Sale | 6,523 | $258.74 | $1,687,754 |
| Jul 20, 2026 | Broadhurst Vanessa | EVP, Global Corp Affairs | M Exercise | 11,129 | Not measured | Not measured |
| Jul 20, 2026 | Broadhurst Vanessa | EVP, Global Corp Affairs | M Exercise | 11,925 | Not measured | Not measured |
| Jul 20, 2026 | Broadhurst Vanessa | EVP, Global Corp Affairs | S Sale | 23,054 | $251.27 | $5,792,686 |
| Jul 20, 2026 | Broadhurst Vanessa | EVP, Global Corp Affairs | M Exercise | 11,129 | $129.51 | $1,441,317 |
| Jul 20, 2026 | Broadhurst Vanessa | EVP, Global Corp Affairs | M Exercise | 11,925 | $131.94 | $1,573,385 |
| Jun 11, 2026 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M Exercise | 10,000 | $115.67 | $1,156,700 |
| Jun 11, 2026 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | S Sale | 10,000 | $241.15 | $2,411,500 |
| Jun 11, 2026 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M Exercise | 10,000 | Not measured | Not measured |
| Jun 9, 2026 | Woods Eugene A. | Director | A Award | 161 | $232.79 | $37,500 |
| Jun 9, 2026 | HEWSON MARILLYN A | Director | A Award | 215 | $232.79 | $50,000 |
| Jun 9, 2026 | Pinto Daniel E | Director | A Award | 134 | $232.79 | $31,250 |
| May 1, 2026 | REED JOHN C | EVP, Innovative Medicine, R&D | M Exercise | 25,255 | Not measured | Not measured |
| May 1, 2026 | REED JOHN C | EVP, Innovative Medicine, R&D | F Tax Payment | 11,002 | $229.85 | $2,528,810 |
| May 1, 2026 | REED JOHN C | EVP, Innovative Medicine, R&D | M Exercise | 25,255 | Not measured | Not measured |
| Apr 23, 2026 | Doudna Jennifer A | Director | A Award | 975 | Not measured | Not measured |
| Apr 23, 2026 | Beckerle Mary C | Director | A Award | 975 | Not measured | Not measured |
| Apr 23, 2026 | Johnson Paula A | Director | A Award | 975 | Not measured | Not measured |
| Apr 23, 2026 | McClellan Mark B. | Director | A Award | 975 | Not measured | Not measured |
| Apr 23, 2026 | Pinto Daniel E | Director | A Award | 1,712 | Not measured | Not measured |
| Apr 23, 2026 | MORIKIS JOHN G | Director | A Award | 1,540 | Not measured | Not measured |
| Apr 23, 2026 | Joly Hubert | Director | A Award | 975 | Not measured | Not measured |
| Apr 23, 2026 | HEWSON MARILLYN A | Director | A Award | 975 | Not measured | Not measured |
| Apr 23, 2026 | Woods Eugene A. | Director | A Award | 975 | Not measured | Not measured |
| Apr 23, 2026 | West Nadja | Director | A Award | 975 | Not measured | Not measured |
| Apr 23, 2026 | WEINBERGER MARK A | Director | A Award | 975 | Not measured | Not measured |
| Mar 10, 2026 | Woods Eugene A. | Director | A Award | 155 | $242.14 | $37,500 |
| Mar 10, 2026 | Pinto Daniel E | Director | A Award | 129 | $242.14 | $31,250 |
| Mar 10, 2026 | HEWSON MARILLYN A | Director | A Award | 206 | $242.14 | $50,000 |
The full Form 4 history is on the JNJ company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.